TY - JOUR
T1 - The impact of telomere erosion on memory CD8+ T cells in patients with X-linked lymphoproliferative syndrome
AU - Plunkett, FJ
AU - Franzese, O
AU - Belaramani, LL
AU - Fletcher, JM
AU - Gilmour, KC
AU - Sharifi, R
AU - Khan, Naeem
AU - Hislop, Andrew
AU - Cara, A
AU - Salmon, Michael
AU - Gaspar, HB
AU - Rustin, MHA
AU - Webster, D
AU - Akbar, AN
PY - 2005/8/1
Y1 - 2005/8/1
N2 - Patients with X-linked lymphoproliferative syndrome (XLP) experience excessive T cell proliferation after primary Epstein-Barr virus (EBV) infection, due to mutations in the signalling lymphocyte activation molecule (SLAM) associated protein (SAP) molecule. We examined the impact of dysfunctional proliferative control on the extent of CD8+ T cell differentiation in XLP patients who recovered from primary EBV infection. Although these young patients have normal numbers of lytic and latent EBV-epitope-specific CD8+ T cells, they were extremely differentiated as defined by loss of CCR7 and CD27, low telomerase activity and very short telomeres. This was not a direct effect arising from the loss of SAP, but was due to excessive T cell stimulation due to this defect. Thus, transduction of XLP CD8+ T cells with the catalytic component of telomerase (hTERT), but not SAP, prevented telomere loss and considerably extended proliferative lifespan in vitro. These results indicate that excessive proliferation in CD8+ T cells in XLP patients may lead to end-stage differentiation and loss of functional EBV-specific CD8+ T cells through replicative senescence. This may contribute to the defective immunity found in XLP patients who survive acute EBV infection who develop EBV-related B cell lymphomas before the fourth decade of life.
AB - Patients with X-linked lymphoproliferative syndrome (XLP) experience excessive T cell proliferation after primary Epstein-Barr virus (EBV) infection, due to mutations in the signalling lymphocyte activation molecule (SLAM) associated protein (SAP) molecule. We examined the impact of dysfunctional proliferative control on the extent of CD8+ T cell differentiation in XLP patients who recovered from primary EBV infection. Although these young patients have normal numbers of lytic and latent EBV-epitope-specific CD8+ T cells, they were extremely differentiated as defined by loss of CCR7 and CD27, low telomerase activity and very short telomeres. This was not a direct effect arising from the loss of SAP, but was due to excessive T cell stimulation due to this defect. Thus, transduction of XLP CD8+ T cells with the catalytic component of telomerase (hTERT), but not SAP, prevented telomere loss and considerably extended proliferative lifespan in vitro. These results indicate that excessive proliferation in CD8+ T cells in XLP patients may lead to end-stage differentiation and loss of functional EBV-specific CD8+ T cells through replicative senescence. This may contribute to the defective immunity found in XLP patients who survive acute EBV infection who develop EBV-related B cell lymphomas before the fourth decade of life.
KW - XLP
KW - T cell memory
KW - telomere
KW - EBV
UR - http://www.scopus.com/inward/record.url?scp=21344434558&partnerID=8YFLogxK
U2 - 10.1016/j.mad.2005.03.006
DO - 10.1016/j.mad.2005.03.006
M3 - Article
C2 - 15992610
VL - 126
SP - 855
EP - 865
JO - Mechanisms of Ageing and Development
JF - Mechanisms of Ageing and Development
ER -